Agios Pharmaceuticals (NasdaqGS:AGIO) Update / Briefing November 19, 2025 08:00 AM ET Speaker3Thank you for joining today's call. At Agios, everything begins with connection. We partner closely with the rare disease communities we serve to deeply understand their challenges and priorities. This collaboration drives our ability to develop and deliver innovative medicines with the potential to transform lives. As you'll be reminded on this call, sickle cell is a complex and devastating disease. In the U.S., m ...